Waters Corporation $WAT Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC trimmed its position in Waters Corporation (NYSE:WAT) by 93.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,785 shares of the medical instruments supplier’s stock after selling 86,130 shares during the period. SG Americas Securities LLC’s holdings in Waters were worth $1,734,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of WAT. UMB Bank n.a. lifted its stake in shares of Waters by 2.8% in the 2nd quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock worth $368,000 after acquiring an additional 29 shares during the period. Integrated Wealth Concepts LLC raised its holdings in Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares in the last quarter. Exchange Traded Concepts LLC lifted its position in Waters by 5.9% in the third quarter. Exchange Traded Concepts LLC now owns 630 shares of the medical instruments supplier’s stock valued at $189,000 after purchasing an additional 35 shares during the period. Penserra Capital Management LLC lifted its position in Waters by 13.1% in the second quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 38 shares during the period. Finally, CW Advisors LLC boosted its holdings in Waters by 2.0% in the 2nd quarter. CW Advisors LLC now owns 2,112 shares of the medical instruments supplier’s stock valued at $737,000 after purchasing an additional 42 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Trading Up 0.3%

Shares of WAT stock opened at $394.34 on Friday. The stock has a market cap of $23.48 billion, a P/E ratio of 36.24, a P/E/G ratio of 3.29 and a beta of 1.16. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The business has a fifty day simple moving average of $389.00 and a 200-day simple moving average of $340.28.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, November 4th. The medical instruments supplier reported $3.40 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.19. Waters had a net margin of 20.89% and a return on equity of 36.59%. The firm had revenue of $799.89 million for the quarter, compared to analysts’ expectations of $780.05 million. During the same period in the prior year, the company earned $2.93 EPS. The firm’s revenue was up 8.1% on a year-over-year basis. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. On average, analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on WAT. Guggenheim began coverage on Waters in a research note on Tuesday, January 6th. They set a “buy” rating and a $440.00 target price for the company. Wolfe Research upgraded Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 price objective for the company in a research report on Wednesday, December 10th. JPMorgan Chase & Co. boosted their target price on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. TD Cowen increased their price target on shares of Waters from $345.00 to $390.00 and gave the company a “hold” rating in a report on Wednesday, November 5th. Finally, Cowen reiterated a “hold” rating on shares of Waters in a research note on Wednesday, November 5th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $395.00.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.